NorDiag ASA invites to a presentation of the results on February 16, 2012 at 8:30 am at the offices of NorDiag in Frysjaveien 40, entrance 12, 4.floor, Oslo.
 
Please confirm your participation to investor@nordiag.com, or by calling +47 22 02 65 91. Shareholders who wish to receive the quarterly report by mail are requested to send an email regarding this to the same email address.
 
Representatives from the Company will be CEO Mårten Wigstøl and CFO Tone Kvåle.
 
The report and the presentation will be published on NorDiag's homepage www.nordiag.com.
 
Contact:
CFO Tone Kvåle, phone: +47 915 19 576.
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 31.6 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.

Read the notice in Norwegian here.